2022 Information Coming Soon!
Simone OostindieScientist, Early Stage Translational Research at Genmab
Profile
Simone C. Oostindie is a Scientist in the Early Stage Translational Research Team at Genmab. She joined Genmab in 2014 and specializes in preclinical development of novel antibody therapeutics. Her current work focusses on translational research with respect to antibody biology, novel antibody technology platforms and next-generation antibody therapeutics, as part of her training to obtain her PhD at the Leiden University Medical Center in The Netherlands. She holds an MSc degree in Biology from the University of Wageningen.
Agenda Sessions
Exploiting and Understanding Avidity Engineering of Antibodies
15:45View SessionThe DuoHexaBody® Platform: Combining Dual Epitope Targeting and Fc Engineering to Boost Antibody Functional Responses
On DemandView Session